Inflarx Nv logo

Inflarx Nv Share Price Today

(NASDAQ: IFRX)

Inflarx Nv share price is $1.26 & ₹109.58 as on 6 Mar 2025, 2.30 'hrs' IST

$1.26

0.03

(2.44%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Inflarx Nv share price in Dollar and Rupees. Guide to invest in Inflarx Nv stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Inflarx Nv, along with analyst recommendations, forecasts, and comprehensive financials.

Inflarx Nv share price movements

  • Today's Low: $1.17
    Today's High: $1.28

    Day's Volatility :8.59%

  • 52 Weeks Low: $1.17
    52 Weeks High: $2.82

    52 Weeks Volatility :58.61%

Inflarx Nv (IFRX) Returns

PeriodInflarx NvIndex (Russel 2000)
3 Months
-50.0%
0.0%
6 Months
-21.66%
0.0%
1 Year
-29.31%
0.0%
3 Years
-44.09%
-11.6%

Inflarx Nv (IFRX) Key Statistics

in dollars & INR

Previous Close
$1.23
Open
$1.3
Today's High
$1.28
Today's Low
$1.17
Market Capitalization
$82.6M
Today's Volume
$43.6K
52 Week High
$2.815
52 Week Low
$1.165
Revenue TTM
$168.5K
EBITDA
$-43.1M
Earnings Per Share (EPS)
$-1.02
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-62.07%

How to invest in Inflarx Nv Stock (IFRX) from India?

It is very easy for Indian residents to invest directly in Inflarx Nv from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Inflarx Nv stock in both Indian Rupees (INR) and US Dollars (USD). Search for Inflarx Nv or IFRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Inflarx Nv or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Inflarx Nv shares which would translate to 0.690 fractional shares of Inflarx Nv as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Inflarx Nv, in just a few clicks!

Returns in Inflarx Nv (IFRX) for Indian investors in Rupees

The Inflarx Nv stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Inflarx Nv investment value today

Current value as on today

₹77,377

Returns

₹22,623

(-22.62%)

Returns from Inflarx Nv Stock

₹27,586 (-27.59%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Inflarx Nv (IFRX)

18%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Inflarx Nv Stock from India on INDmoney has increased by 18% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Inflarx Nv

  • Suvretta Capital Management, LLC

    8.54%

  • 683 Capital Management LLC

    3.08%

  • Morgan Stanley - Brokerage Accounts

    3.04%

  • Northern Trust Corp

    0.99%

  • UBS O'Connor LLC

    0.93%

  • Eversept Partners, LLC

    0.73%

Analyst Recommendation on Inflarx Nv

Buy

    81%Buy

    18%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Inflarx Nv(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Inflarx Nv Stock (IFRX)

What analysts predicted

Upside of 587.98%

Target:

$8.67

Current:

$1.26

Insights on Inflarx Nv Stock (Ticker Symbol: IFRX)

  • Price Movement

    In the last 1 month, IFRX stock has moved down by -50.8%
  • IFRX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 93.6%
  • IFRX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 89.4%
  • Price to Sales

    ForIFRX every $1 of sales, investors are willing to pay $410.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Inflarx Nv Technicals Summary

Sell

Neutral

Buy

Inflarx Nv is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Inflarx Nv (IFRX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Inflarx Nv logo
-50.2%
-21.66%
-29.31%
-44.09%
-67.72%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Inflarx Nv logo
NA
NA
NA
-0.98
-0.62
-0.26
NA
1.11
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Inflarx Nv logo
Buy
$82.6M
-67.72%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Inflarx Nv

InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase III clinical trial for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; for the treatment of anti-neutrophil cytoplasm antibody associated vasculitis, a rare and life-threatening autoimmune disease that is in Phase II trial; to treat pyoderma gangraenosum, a chronic inflammatory skin disorder that is in Phase IIa exploratory study; and for the treatment of PD-1/PD-L1 inhibitor resistant/refractory locally advanced or metastatic cutaneous squamous cell carcinoma that is in Phase II clinical development stage. The company develops INF904, an oral, small molecule drug candidate for the chronic inflammatory and autoimmune diseases; IFX002 that is in pre-clinical development stage for the treatment of chronic inflammation and autoimmune diseases; and Gohibic (vilobelimab) for the treatment of COVID-19 and broader ARDS. It has co-development agreement with Beijing Defengrei Biotechnology Co. Ltd.; and clinical trial collaboration and supply agreement with Merck & Co. Inc. The company was formerly known as Fireman B.V. and changed its name to InflaRx N.V. in 2017. InflaRx N.V. was founded in 2007 and is headquartered in Jena, Germany.
Organization
Inflarx Nv
Employees
62
CEO
Dr. Niels C. Riedemann M.D., Ph.D.
Industry
Health Technology

Management People of Inflarx Nv

NameTitle
Dr. Niels C. Riedemann M.D., Ph.D.
Co-Founder, CEO & Executive Director
Prof. Renfeng Guo M.D.
Co-Founder, Chief Scientific Officer & Executive Director
Dr. Thomas Taapken Ph.D.
Chief Financial Officer
Ms. Derval O'Carroll
Senior VP and Global Head of Regulatory Affairs & Compliance
Dr. Camilla Chong M.D.
Chief Medical Officer
Mr. Jan Medina CFA
Head of Investor Relations & VP
Mr. Christian Schmid
VP and Head of Legal Affairs & General Counsel
Ms. Nicole Bertsch
Senior Director & Head of Human Resources
Dr. Maria Habel PH.D.
VP, Head of Preclinical R&D and QC
Dr. Bruce P. Burnett Ph.D.
VP & Head of Medical Affairs

Important FAQs about investing in IFRX Stock from India :

What is Inflarx Nv share price today?

Inflarx Nv share price today stands at $1.26, Open: $1.30 ; Previous Close: $1.23 ; High: $1.28 ; Low: $1.17 ; 52 Week High: $2.82 ; 52 Week Low: $1.17.

The stock opens at $1.30, after a previous close of $1.23. The stock reached a daily high of $1.28 and a low of $1.17, with a 52-week high of $2.82 and a 52-week low of $1.17.

Can Indians buy Inflarx Nv shares?

Yes, Indians can invest in the Inflarx Nv (IFRX) from India.

With INDmoney, you can buy Inflarx Nv at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Inflarx Nv at zero transaction cost.

How can I buy Inflarx Nv shares from India?

It is very easy to buy Inflarx Nv from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Inflarx Nv (IFRX) be purchased?

Yes, you can buy fractional shares of Inflarx Nv with INDmoney app.

What are the documents required to start investing in Inflarx Nv stocks?

To start investing in Inflarx Nv, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Inflarx Nv Stock (IFRX)?

Today’s highest price of Inflarx Nv (IFRX) is $1.28.

Today’s lowest price of Inflarx Nv (IFRX) is $1.17.

What is today's market capitalisation of Inflarx Nv?

Today's market capitalisation of Inflarx Nv IFRX is 82.6M

What is the 52 Week High and Low Range of Inflarx Nv Stock (IFRX)?

  • 52 Week High

    $2.82

  • 52 Week Low

    $1.17

What are the historical returns of Inflarx Nv (IFRX)?

  • 1 Month Returns

    -50.2%

  • 3 Months Returns

    -21.66%

  • 1 Year Returns

    -29.31%

  • 5 Years Returns

    -67.72%

Who is the Chief Executive Officer (CEO) of Inflarx Nv ?

Dr. Niels C. Riedemann M.D., Ph.D. is the current Chief Executive Officer (CEO) of Inflarx Nv.